Product Information
PYRAZINAMIDE 500 MG TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $1.4536 per EA under NDC 00054081222. Its NADAC has been published 61 times since Apr 30, 2025.
Strength
500 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054081222
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PYRAZINAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA081319On Market Since
8/30/2024
Pharmacological Classes
Price Statistics
The NADAC for PYRAZINAMIDE 500 MG TABLET has been published 61 times since Apr 30, 2025, and over the history we have for it it has declined 41.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4536 per EA |
|---|---|
| All-time high | $2.5260 (Aug 13, 2025) |
| All-time low | $1.4536 (Jun 17, 2026) |
| 52-week high | $2.5260 |
| 52-week low | $1.4536 |
| Median price | $2.1984 |
| Average price | $2.0937 |
| Largest weekly change | -9.0% (Jan 21, 2026) |
| Weeks tracked | 61 |
| Tracking since | Apr 30, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PYRAZINAMIDE 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PYRAZINAMIDE 500 MG TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $1.4536 per EA (NDC 00054081222), effective Jun 24, 2026.
How has the price of PYRAZINAMIDE 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for PYRAZINAMIDE 500 MG TABLET has declined 41.4%. It has been tracked across 61 weekly CMS publications since Apr 30, 2025.
What are the highest and lowest recorded NADAC prices for PYRAZINAMIDE 500 MG TABLET?
Since Apr 30, 2025, the NADAC for PYRAZINAMIDE 500 MG TABLET has ranged from a low of $1.4536 (Jun 17, 2026) to a high of $2.5260 (Aug 13, 2025), with a median of $2.1984 per EA.
Are there cheaper alternatives to PYRAZINAMIDE 500 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as PYRAZINAMIDE 500 MG TABLET, but none are currently priced below it.
Who manufactures PYRAZINAMIDE 500 MG TABLET?
PYRAZINAMIDE 500 MG TABLET (NDC 00054081222) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification